Form 4 for CRL Charles River Laboratories
Accepted 2022-02-01 00:00:00 ET · period of report 2021-09-23 · accession 0001127602-22-002799 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-01 | 2021-09-23 | CRL | Girshick Birgit | COO, Corp. Executive VP | G - Gift | $0.00 | -531 | 27.1K | -2% | $0 | |
| 2022-02-01 | 2022-01-28 | CRL | Girshick Birgit | COO, Corp. Executive VP | A - Grant | $0.00 | +11.0K | 38.1K | +41% | $0 | |
| 2022-02-01 | 2022-01-28 | CRL | Girshick Birgit | COO, Corp. Executive VP | F - Tax | $312.24 | -3,877 | 34.2K | -10% | -$1.21M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-23 | G | D | 531 | $0.00 | 27,071 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-28 | A | A | 11,029 | $0.00 | 38,100 | D | — | — | (F1) Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 22, 2019. |
| 3 | Common | Common Stock | 2022-01-28 | F | D | 3,877 | $312.24 | 34,223 | D | — | — |